768 related articles for article (PubMed ID: 33424664)
1. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.
Garakani A; Murrough JW; Freire RC; Thom RP; Larkin K; Buono FD; Iosifescu DV
Front Psychiatry; 2020; 11():595584. PubMed ID: 33424664
[TBL] [Abstract][Full Text] [Related]
2. Psychopharmacology of anxiety disorders.
Cassano GB; Baldini Rossi N; Pini S
Dialogues Clin Neurosci; 2002 Sep; 4(3):271-85. PubMed ID: 22033867
[TBL] [Abstract][Full Text] [Related]
3. Current and Novel Psychopharmacological Drugs for Anxiety Disorders.
Bandelow B
Adv Exp Med Biol; 2020; 1191():347-365. PubMed ID: 32002937
[TBL] [Abstract][Full Text] [Related]
4. The pharmacologic treatment of anxiety disorders: a review of progress.
Ravindran LN; Stein MB
J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.
Strawn JR; Geracioti L; Rajdev N; Clemenza K; Levine A
Expert Opin Pharmacother; 2018 Jul; 19(10):1057-1070. PubMed ID: 30056792
[TBL] [Abstract][Full Text] [Related]
6. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997.
Uhlenhuth EH; Balter MB; Ban TA; Yang K
Depress Anxiety; 1999; 9(3):107-16. PubMed ID: 10356648
[TBL] [Abstract][Full Text] [Related]
7. Non-Antidepressant Treatment of Generalized Anxiety Disorder.
Zahreddine N; Richa S
Curr Clin Pharmacol; 2015; 10(2):86-96. PubMed ID: 23438725
[TBL] [Abstract][Full Text] [Related]
8. An umbrella review on the use of antipsychotics in anxiety disorders: A registered report protocol.
Garakani A; Freire RC; Buono FD; Thom RP; Larkin K; Funaro MC; Salehi M; Perez-Rodriguez MM
PLoS One; 2022; 17(6):e0269772. PubMed ID: 35709149
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.
Gao K; Muzina D; Gajwani P; Calabrese JR
J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818
[TBL] [Abstract][Full Text] [Related]
10. Paroxetine: an update of its use in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
Drugs; 2002; 62(4):655-703. PubMed ID: 11893234
[TBL] [Abstract][Full Text] [Related]
11. Initial severity and antidepressant efficacy for anxiety disorders, obsessive-compulsive disorder, and posttraumatic stress disorder: An individual patient data meta-analysis.
de Vries YA; Roest AM; Burgerhof JGM; de Jonge P
Depress Anxiety; 2018 Jun; 35(6):515-522. PubMed ID: 29659102
[TBL] [Abstract][Full Text] [Related]
12. Pregabalin for the treatment of social anxiety disorder.
Kawalec P; Cierniak A; Pilc A; Nowak G
Expert Opin Investig Drugs; 2015 Apr; 24(4):585-94. PubMed ID: 25361817
[TBL] [Abstract][Full Text] [Related]
13. The role of duloxetine in the treatment of anxiety disorders.
De Berardis D; Serroni N; Carano A; Scali M; Valchera A; Campanella D; D'Albenzio A; Di Giuseppe B; Moschetta FS; Salerno RM; Ferro FM
Neuropsychiatr Dis Treat; 2008 Oct; 4(5):929-35. PubMed ID: 19183783
[TBL] [Abstract][Full Text] [Related]
14. Generalised anxiety disorder: treatment options.
Sramek JJ; Zarotsky V; Cutler NR
Drugs; 2002; 62(11):1635-48. PubMed ID: 12109925
[TBL] [Abstract][Full Text] [Related]
15. New frontiers in the pharmacological treatment of social anxiety disorder in adults: an up-to-date comprehensive overview.
Caldiroli A; Capuzzi E; Tagliabue I; Ledda L; Clerici M; Buoli M
Expert Opin Pharmacother; 2023 Feb; 24(2):207-219. PubMed ID: 36519357
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy of generalized anxiety disorder.
Davidson JR
J Clin Psychiatry; 2001; 62 Suppl 11():46-50; discussion 51-2. PubMed ID: 11414551
[TBL] [Abstract][Full Text] [Related]
17. Treatment of generalized anxiety disorder: a comprehensive review of the literature for psychopharmacologic alternatives to newer antidepressants and benzodiazepines.
Huh J; Goebert D; Takeshita J; Lu BY; Kang M
Prim Care Companion CNS Disord; 2011; 13(2):. PubMed ID: 21977338
[TBL] [Abstract][Full Text] [Related]
18. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders.
Bandelow B; Allgulander C; Baldwin DS; Costa DLDC; Denys D; Dilbaz N; Domschke K; Eriksson E; Fineberg NA; Hättenschwiler J; Hollander E; Kaiya H; Karavaeva T; Kasper S; Katzman M; Kim YK; Inoue T; Lim L; Masdrakis V; Menchón JM; Miguel EC; Möller HJ; Nardi AE; Pallanti S; Perna G; Rujescu D; Starcevic V; Stein DJ; Tsai SJ; Van Ameringen M; Vasileva A; Wang Z; Zohar J
World J Biol Psychiatry; 2023 Feb; 24(2):79-117. PubMed ID: 35900161
[TBL] [Abstract][Full Text] [Related]
19. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Algorithm for Generalized Anxiety Disorder.
Abejuela HR; Osser DN
Harv Rev Psychiatry; 2016; 24(4):243-56. PubMed ID: 27384395
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
